These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1673471)

  • 41. Blood pressure variability in patients on beta-blockers.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):25-6. PubMed ID: 14620
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of melatonin and propranolol on sleep of the rat.
    Mendelson WB; Gillin JC; Dawson SD; Lewy AJ; Wyatt RJ
    Brain Res; 1980 Nov; 201(1):240-4. PubMed ID: 7417837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of repeated doses of scopolamine on the electroencephalographic stages of sleep in normal volunteers.
    Sagalés T; Erill S; Domino EF
    Clin Pharmacol Ther; 1975 Dec; 18(6):727-32. PubMed ID: 173490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
    Suemaru K; Gomita Y; Furuno K; Araki Y
    Pharmacol Biochem Behav; 1993 Sep; 46(1):131-3. PubMed ID: 7902979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. REM sleep suppression by monoamine reuptake blockade: development of tolerance with repeated drug administration.
    Ross RJ; Ball WA; Gresch PJ; Morrison AR
    Biol Psychiatry; 1990 Aug; 28(3):231-9. PubMed ID: 2165825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-blockers as a cause of violent rapid eye movement sleep behavior disorder: a poorly recognized but common cause of violent parasomnias.
    Morrison I; Frangulyan R; Riha RL
    Am J Med; 2011 Jan; 124(1):e11. PubMed ID: 20887968
    [No Abstract]   [Full Text] [Related]  

  • 47. Experimental analysis of anti-hypertensive effects of beta-adrenergic blocking agents.
    Marmo E; Caputi AP; Rossi F; Lampa E; Vacca C; Brita G; Saini RK; Di Nola R
    Agressologie; 1976; 17(5):279-95. PubMed ID: 13671
    [No Abstract]   [Full Text] [Related]  

  • 48. Ambulatory blood pressure during administration of atenolol, metoprolol, pindolol, and slow release propranolol.
    Br Med J (Clin Res Ed); 1983 Jan; 286(6361):306-7. PubMed ID: 6130815
    [No Abstract]   [Full Text] [Related]  

  • 49. Hypersomnolence with beta-adrenergic blockers.
    Thachil J; Zeller JR; Kochar MS
    Chest; 1987 Nov; 92(5):943-4. PubMed ID: 3665616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic Ro 15-1788 treatment increases REM sleep in rats.
    O'Connor SD; Urbancic M; Marczynski TJ; Radulovacki M
    Brain Res Bull; 1991 Aug; 27(2):251-3. PubMed ID: 1742613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circadian phase dependency of the effects of different beta-receptor blocking drugs on motor activity of rats. Importance of drug lipophilicity.
    Lemmer B; Neumann G
    Arzneimittelforschung; 1987 Mar; 37(3):321-5. PubMed ID: 2885007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Actual knowledge on beta blocking agents in psychiatry (author's transl)].
    Scharbach H
    Acta Psychiatr Belg; 1978; 78(2):358-73. PubMed ID: 27946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of sleep disorders induced by beta-adrenergic receptor blocking agents based on receptor occupancy.
    Yamada Y; Shibuya F; Hamada J; Sawada Y; Iga T
    J Pharmacokinet Biopharm; 1995 Apr; 23(2):131-45. PubMed ID: 8719233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action.
    Koella WP
    Eur J Clin Pharmacol; 1985; 28 Suppl():55-63. PubMed ID: 2865151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta-blockers and central nervous system side effects.
    McAinsh J; Cruickshank JM
    Pharmacol Ther; 1990; 46(2):163-97. PubMed ID: 1969642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apha-adrenergic receptor blockade increases human REM sleep.
    Oswald I; Thacore VR; Adam K; Brezinová V
    Br J Clin Pharmacol; 1975 Apr; 2(2):107-10. PubMed ID: 186089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biobehavioral sequellae associated with adrenergic-inhibiting antihypertensive agents: a critical review.
    Rosen RC; Kostis JB
    Health Psychol; 1985; 4(6):579-604. PubMed ID: 3913603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of mebutamate on the electroencephalographic sleep profile.
    Whitsett TL; Hoyt HJ; Czerwinski AW; Clark ML
    Clin Pharmacol Ther; 1974 Jan; 15(1):51-8. PubMed ID: 4357727
    [No Abstract]   [Full Text] [Related]  

  • 59. The effects of beta-adrenergic blocking agents on the blood pressure of normotensive and hypertensive rats.
    Glavas E; Gudeska S; Stojanova D; Nikodijević B
    God Zb Med Fak Skopje; 1976; 22():5-9. PubMed ID: 15930
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of nadolol on blood pressure, sleep efficiency, and sleep stages.
    Kales A; Bixler EO; Vela-Bueno A; Cadieux RJ; Manfredi RL; Bitzer S; Kantner T
    Clin Pharmacol Ther; 1988 Jun; 43(6):655-62. PubMed ID: 3378387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.